The IFN-α, stimulating the expression of IFN-γ receptor (IFNGR1, and IFNGR2) [53] could contribute to reverse the observed low levels of this membrane receptor in BCC cells. The gene discussed is IFNA1; the disease is skin basal cell carcinoma.